Clinical Trial: Observational Registry Evaluating the Clinical Impact of the Blood-Based Biomarker Test for Early-Stage Pancreatic Ductal Adenocarcinoma

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805681) titled 'Observational Registry Evaluating the Clinical Impact of the Blood-Based Biomarker Test for Early-Stage Pancreatic Ductal Adenocarcinoma' on April 24.

Brief Summary: The goal of this observational registry is to examine the changes made to pancreatic cancer surveillance management following the real-world clinical use of PancreaSure testing among individuals at increased risk for pancreatic ductal adenocarcinoma. The main question it aims to answer is, does surveillance management and intent change following the return of PancreaSure binary results.

Study Start Date: Sept., 2026

Study Type: OBSERVATIONAL

Condition: PDAC - Pancre...